Pre-exposure Prophylaxis of COVID-19
Showing 1 - 25 of >10,000
Severe COVID-19 Infection in CLL or B-NHL Who Received
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- (no location specified)
Apr 6, 2023
COVID-19 Trial in New York (Hydroxychloroquine (HCQ))
Completed
- COVID-19
- Hydroxychloroquine (HCQ)
-
New York, New YorkNYU Langone Health
Dec 12, 2022
COVID-19, SARS-CoV-2 Trial in Moscow, St Petersburg (Biological: AZD3152, Biological: Placebo)
Not yet recruiting
- COVID-19, SARS-CoV-2
- Biological: AZD3152
- Biological: Placebo
-
Moscow, Russian Federation
- +5 more
Sep 26, 2023
EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in
Recruiting
- COVID-19
-
Abu Dhabi, United Arab Emirates
- +1 more
Jul 20, 2022
DoD Health System
Not yet recruiting
- COVID-19; SARS-CoV-2; 2019 Novel Coronavirus Disease
- (no location specified)
Oct 4, 2022
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
Coronavirus Disease 2019 (COVID-19) Trial in United Kingdom, United States (AZD7442 (tixagevimab [AZD8895] + cilgavimab
Active, not recruiting
- Coronavirus Disease 2019 (COVID-19)
- AZD7442 (tixagevimab [AZD8895] + cilgavimab [AZD1061])
-
Birmingham, Alabama
- +15 more
Nov 7, 2022
COVID-19, SARS-CoV-2 Trial in Worldwide (AZD5156, Placebo, AZD7442 (EVUSHELD™))
Recruiting
- COVID-19, SARS-CoV-2
- AZD5156
- +2 more
-
Buenos Aires, Argentina
- +20 more
Jan 12, 2023
COVID-19 Prevention Trial in Louisville (Q-Griffithsin, Placebo)
Completed
- COVID-19 Prevention
- Q-Griffithsin
- Placebo
-
Louisville, KentuckyUniversity of Louisville
Apr 28, 2022
COVID-19, Corona Virus Infection, ARDS Trial in Minneapolis (Hydroxychloroquine, Placebo)
Pre-Exposure Prophylaxis, Coronavirus, SARS-CoV 2 Trial in Toronto (Hydroxychloroquine, Placebo oral tablet)
Terminated
- Pre-Exposure Prophylaxis
- +2 more
- Hydroxychloroquine
- Placebo oral tablet
-
Toronto, Ontario, CanadaUniversity Health Network
Apr 27, 2021
SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin
Completed
- Covid19
- Ivermectin 6 Mg Oral Tablet
-
Puerto Plata, Dominican Republic
- +1 more
Apr 10, 2021
COVID-19 Trial (IBIO123, Placebo)
Not yet recruiting
- COVID-19
- IBIO123
- Placebo
- (no location specified)
Dec 5, 2022
COVID-19 Trial in Worldwide (AZD7442, Placebo)
SARS-CoV Infection, COVID-19 Trial (Mitoquinone/mitoquinol mesylate, Placebo)
Not yet recruiting
- SARS-CoV Infection
- COVID-19
- Mitoquinone/mitoquinol mesylate
- Placebo
- (no location specified)
Jun 1, 2023
Pre-exposure Prophylaxis Trial in University Park (Injectable PrEP information, Oral PrEP information)
Not yet recruiting
- Pre-exposure Prophylaxis
- Injectable PrEP information
- Oral PrEP information
-
University Park, PennsylvaniaPennsylvania State University
Feb 13, 2023